Skip to main content

Analysis of parameters in critically ill patients influencing amikacin peak levels


Recent studies demonstrate that a loading dose of 25 mg/kg (total body weight) of amikacin in septic patients is required to reach a sufficient peak concentration. This study examines parameters influencing the relation between amikacin dose and peak concentration.


In this retrospective study we looked at 47 patients (128 peak levels) between 2003 and 2012. Multivariate linear regression analysis was done for several parameters: administered dose calculated with total body weight, ideal body weight, adjusted body weight, type of intensive care patient, BMI, daily fluid balance, SOFA score and APACHE score, and patient characteristics were analyzed.


A linear correlation between dose and amikacin peak level was confirmed (Figure 1). A total 54.69% of all amikacin administrations did not result in a therapeutic peak level. The multivariate linear regression analysis showed the best linear correlation with adjusted body weight and SOFA score. The comparison of variables between four patient groups, based on the deviation between measured peak level and predicted peak level (according the linear correlation), showed new variables that may influence peak level.

Figure 1
figure 1

Correlation between dose of amikacin and peak concentration.


This confirms that low doses (<18 mg/kg) of amikacin in intensive care patients seldom result in a therapeutic peak level. The proposed loading dose of 25 mg/kg is good for reaching a therapeutic level, although 29.6% remains subtherapeutic. Due to the linear correlation, more therapeutic levels may be reached with higher doses (25 to 30 mg/kg). New variables need further investigation to explain the high variability in achieved peak level.


  1. Delattre IK, et al.: Ther Drug Monit. 2010, 32: 749-756. 10.1097/FTD.0b013e3181f675c2

    Article  CAS  PubMed  Google Scholar 

  2. Taccone FS, et al.: Crit Care. 2010, 14: R53. 10.1186/cc8945

    Article  PubMed Central  PubMed  Google Scholar 

  3. Gálvez R, et al.: Int J Antimicrobial Agents. 2011, 38: 146-151. 10.1016/j.ijantimicag.2011.03.022

    Article  Google Scholar 

  4. Avent ML, et al.: Internal Med J. 2011, 41: 441-449. 10.1111/j.1445-5994.2011.02452.x

    Article  CAS  Google Scholar 

  5. Fernández de Gatta MM, et al.: J Clin Pharm Ther. 1996, 21: 417-421. 10.1111/j.1365-2710.1996.tb00041.x

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Hollevoet, I., Toye, S. & De Waele, J. Analysis of parameters in critically ill patients influencing amikacin peak levels. Crit Care 17 (Suppl 2), P82 (2013).

Download citation

  • Published:

  • DOI:


  • Peak Concentration
  • Linear Correlation
  • Fluid Balance
  • Amikacin
  • Septic Patient